I was watching the health section of the BBC News yesterday and read an interesting bit regarding the drug Lucentis. 12 northern NHS doctors are now using a cheaper version and so had been taken to the High Court by Bayer and Novatis. The NHS WON they case being allowed to use the cheaper version which can now save the NHS millions. This cheaper version is not licenced here in England but is used around the world in the US for Wet age related macular regeneration as have these 12 trusts.
Cheaper versions of the T3 could now be used by the NHS so what is stopping them.
It creates a parallel